You just read:

MTG Biotherapeutics Announces that MTG-201 was Granted Orphan Drug Designation by the US FDA for the Treatment of Malignant Mesothelioma

News provided by

MTG Biotherapeutics

Aug 21, 2015, 06:00 ET